These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2804476)

  • 1. [Reutilization of iron in the body and regulation of iron reserves. The value of plasma transferrin receptor levels].
    Fillet G; Beguin Y
    Bull Mem Acad R Med Belg; 1989; 144(1-2):113-8; discussion 118-20. PubMed ID: 2804476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry of nonheme iron in man. I. Iron proteins and cellular iron metabolism.
    Bezkorovainy A
    Clin Physiol Biochem; 1989; 7(1):1-17. PubMed ID: 2665999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin metabolism and the liver.
    Aisen P
    Semin Liver Dis; 1984 Aug; 4(3):193-206. PubMed ID: 6385268
    [No Abstract]   [Full Text] [Related]  

  • 4. [The transferrin receptor: its role in iron metabolism and its diagnosis utility].
    Vernet M
    Ann Biol Clin (Paris); 1999; 57(1):9-18. PubMed ID: 9920962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of iron metabolism in the mononuclear phagocyte system.
    Kong WN; Lei YH; Chang YZ
    Expert Rev Hematol; 2013 Aug; 6(4):411-8. PubMed ID: 23991927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation.
    Fillet G; Beguin Y; Baldelli L
    Blood; 1989 Aug; 74(2):844-51. PubMed ID: 2502204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iron metabolism in liver diseases].
    Prieto Valtueña J
    Sangre (Barc); 1982; 27(4-B):604-11. PubMed ID: 7157135
    [No Abstract]   [Full Text] [Related]  

  • 9. Adequacy of iron supply for erythropoiesis: in vivo observations in humans.
    Cazzola M; Pootrakul P; Bergamaschi G; Huebers HA; Eng M; Finch CA
    J Lab Clin Med; 1987 Dec; 110(6):734-9. PubMed ID: 3681115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical importance of determining levels of circulating transferrin receptors in blood].
    Cermák J; Brabec V
    Vnitr Lek; 1999 Aug; 45(8):468-72. PubMed ID: 11045146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Storage iron regulation.
    Hershko C
    Prog Hematol; 1977; 10():105-48. PubMed ID: 337357
    [No Abstract]   [Full Text] [Related]  

  • 12. Transferrin: physiologic behavior and clinical implications.
    Huebers HA; Finch CA
    Blood; 1984 Oct; 64(4):763-7. PubMed ID: 6089933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of release of iron from reticuloendothelial system.
    Barry WE; Tallarida R; Rusy BF
    J Reticuloendothel Soc; 1968 Oct; 5(5):412-21. PubMed ID: 5686047
    [No Abstract]   [Full Text] [Related]  

  • 14. Transferrin receptor 2 is frequently expressed in human cancer cell lines.
    Calzolari A; Oliviero I; Deaglio S; Mariani G; Biffoni M; Sposi NM; Malavasi F; Peschle C; Testa U
    Blood Cells Mol Dis; 2007; 39(1):82-91. PubMed ID: 17428703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
    Chang J; Bird R; Clague A; Carter A
    Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron absorption and iron overload.
    Powell LA; Halliday JW
    Clin Gastroenterol; 1981 Sep; 10(3):707-35. PubMed ID: 7032763
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical syndromes of hyperferremia.
    Wilson BO; Bahu RM; Kent G
    Ann Clin Lab Sci (1971); 1971; 1(1):64-73. PubMed ID: 4949763
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular and cellular characterization of transferrin receptor 2.
    Subramaniam VN; Summerville L; Wallace DF
    Cell Biochem Biophys; 2002; 36(2-3):235-9. PubMed ID: 12139409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utilization of senescent red cell and hemolysate iron for erythropoiesis.
    Schade SG; Fried W
    Proc Soc Exp Biol Med; 1976 Jan; 151(1):78-83. PubMed ID: 1250860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble transferrin receptor in hemochromatosis patients during phlebotomy therapy.
    Piéroni L; Mekhloufi F; Thiolières JM; Hainque B; Herson S; Jardel C
    Clin Chim Acta; 2005 Mar; 353(1-2):61-6. PubMed ID: 15698591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.